Work

Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemic

Year: 2021

Type: article

Study design: Observational Study

Source: Healthcare

DOI: 10.1016/j.hjdsi.2021.100581

Authors: Camille E. Morgan, Casey A. Rimland, Griffin J. Bell, Min K. Kim, Tanner Hedrick, Ashley Marx, Brian Bramson, Heidi Swygard, Sonia Napravnik, John L. Schmitz, Shannon S. Carson, William A. Fischer, Joseph J. Eron, Cynthia L. Gay, Jonathan B. Parr

Institutions: University of North Carolina at Chapel Hill, University of North Carolina Health Care

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Abbott Laboratories, World Health Organization, Gilead Sciences, National Institutes of Health, University of North Carolina at Chapel Hill, National Institute of General Medical Sciences

Award: Medical Scientist Training Program

OpenAlex ID: W3197360172

FWCI: 0.079

Cites: 24

Cited by: 1

Related to: 10